Sign In
Buy AIM
$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
Phoenix Copper lists $110mln of corporate copper bonds on TISE
03:27am, Monday, 01'st Jul 2024
Phoenix Copper Ltd (AIM:PXC, OTCQX:PXCLF) highlighted to investors that US$110 million of corporate copper bonds have been admitted to trading on the official list of the International Stock Exchange
Seeing Machines 'one of top picks' in sector, says investment bank
07:39am, Wednesday, 26'th Jun 2024
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) had a 'buy' rating from Stifel reiterated after the company secured a $16.5 million upfront payment from global mining equipment giant Caterpillar for its
Melrose founder Simon Peckham to lead lookalike Rosebank's AIM IPO
06:48am, Monday, 17'th Jun 2024
One of the founders of Melrose Industries PLC (LSE:MRO), alternately criticised as a financial raider or hailed as a highly successful investment company, is reportedly coming back to the market w
AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference
08:55am, Monday, 10'th Jun 2024
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K.
CHICAGO--(BUSINESS WIRE)-- #CRM--Advyzon Investment Management (AIM), a turnkey asset management program (TAMP) under the umbrella of comprehensive technology platform Advyzon, announced today the hir
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series
09:15am, Monday, 03'rd Jun 2024
Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, June 5th at 12:00 PM ET Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on W
AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering
08:30am, Friday, 31'st May 2024
OCALA, Fla., May 31, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a
Bank of England rate cut 'possible' in summer, says deputy governor Broadbent
09:27am, Monday, 20'th May 2024
Ben Broadbent, a member of the Bank of England's rate-setting committee, said the base rate could be cut at some point this summer. Deputy governor Broadbent, who steps down next month after 13 years
AIM ImmunoTech to Participate in Two Upcoming Investor Conferences
09:15am, Monday, 20'th May 2024
OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that AIM Chief Executive Officer Thomas K. Equels will particip
Griffin Mining Limited Announces Annual General Meeting
09:00am, Monday, 20'th May 2024
Annual General Meeting LONDON, UK / ACCESSWIRE / May 20, 2024 / Notice of the thirty seventh Annual General Meeting of Griffin Mining Limited to be held at Clarendon House, 2 Church Street, Hamilton,
AFC forms partnership to supple fuel cell modules with Niftylift
02:38am, Monday, 20'th May 2024
AFC Energy PLC (AIM:AFC, OTC:AFGYF) has won a contract to supply its hydrogen-powered S Series fuel cell modules to Niftylift, one of the largest providers of mobile elevated work platforms (MEWP) in
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
07:30am, Thursday, 16'th May 2024
Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications
Aimia Inc. (AIMFF) Q1 2024 Earnings Call Transcript
12:05pm, Wednesday, 15'th May 2024
Aimia Inc. (OTCPK:AIMFF) Q1 2024 Results Conference Call May 15, 2024 8:30 AM ET Company Participants Joe Racanelli - VP, IR and Communications Tom Finke - Executive Chairman Steve Leonard - Chief Fin
AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast
08:50am, Thursday, 09'th May 2024
OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a conference call and webcast to disc
AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®
08:30am, Monday, 06'th May 2024
OCALA, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the successfully completion of cGMP manufacturing of 9,042 clin
